H&R GmbH & Co. KGaA/€2HRA

1D1W1MYTD1Y5YMAX

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA, headquartered in Salzbergen, Germany, specializes in the development and production of chemical-pharmaceutical specialty products derived from crude oil, as well as precision plastic parts. The company operates through three segments: ChemPharm Refining, which produces paraffins, white oils, plasticizers, and base oils; ChemPharm Sales, focusing on the processing and distribution of similar specialty products; and Plastics, which develops and manufactures precision plastic components for industries such as automotive and medical technology. Founded in 1919, H&R has expanded its operations to include production and distribution sites across Europe, Africa, Asia, and other international markets. The company's strategic positioning emphasizes sustainability through its "green refineries," aiming for residue-free production processes.
Ticker
€2HRA
Sector
Materials
Primary listing
XETRA
Employees
1,688

2HRA Metrics

BasicAdvanced
€267M
104.61
€0.07
0.40
-

Bulls say / Bears say

Preliminary H1 2026 results showed revenue growth to €700.4 million (H1 2025: €653.1 million) and a doubling of EBITDA to €84.4 million (H1 2025: €40.1 million), with net income up to €41.6 million and EPS of €1.12 (TradingView)
Q2 2026 operating performance significantly exceeded expectations, with strong demand and pricing for base oils and solvents—driven by Persian Gulf supply disruptions—likely achieving the lower end of full‐year EBITDA guidance of €85 million by mid‐year (EQS News)
H&R published its FY 2025 Annual and Sustainability Report on March 31, 2026, aligning its sustainability statement for the first time with the EU’s CSRD and ESRS frameworks, enhancing ESG transparency and compliance (WebDisclosure)
The Q2 2026 gain was driven by temporary geopolitical disruptions in the Persian Gulf, and a normalization of supply routes or easing of tensions could materially dampen H&R’s earnings in the second half of 2026 (EQS News)
Operating cash flow turned negative in Q2 2026 at –€22.5 million (Q2 2025: +€32.7 million), leading to a first‐half free cash flow of –€19.5 million and straining liquidity amid higher feedstock costs (TradingView)
The Plastics segment remains a drag, posting a negative H1 2026 EBITDA of –€1.7 million (H1 2025: –€1.9 million) with revenue down to €16.0 million from €18.9 million, limiting diversification benefits (TradingView)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2026.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.